EGFR and lung carcinoma: As shown in our data, the growth of lung cancer cells is more sensitive to SCD1 inhibitors when EGFR is activated, which is consistent with previous finding that SCD1 activity is more essential for the cells with faster growth rate [11, 13, 15, 42].